Disclosure: This post is published by Tristella Advisors, which is included in the advisory firm list below. We have made every effort to evaluate each option using the same criteria we apply to ourselves.
The best clinical AI governance solutions for health systems fall into two distinct categories: software platforms that provide model monitoring, bias detection, audit trails, and drift detection across deployed AI systems, and advisory firms that design governance frameworks, map regulatory requirements, and build the organizational infrastructure that makes governance programs usable in a real clinical environment. Most health systems that are serious about scaling AI will eventually need both, but the sequence matters: governance software operationalizes decisions you have already made, and organizations that deploy monitoring tools before they have a governance framework in place end up with data they do not know how to act on.
If you are earlier in the process and want to understand what clinical AI governance actually is before evaluating vendors or advisors, start with our foundational guide for health system leaders.
This post covers the leading options in each category, the evaluation criteria that are specific to clinical AI, and a framework for deciding which type of help your organization needs first.
For the full regulatory and compliance context behind clinical AI governance, the companion clinical AI governance framework post covers what a governance program needs to address before you start evaluating vendors or advisors.
What clinical AI governance software does
Clinical AI governance software is a category distinct from general AI governance or enterprise risk platforms. The distinction matters because the requirements in a clinical environment are specific.
General AI governance tools are designed for policy management, vendor inventory, regulatory compliance documentation, and risk taxonomy across an enterprise AI portfolio. They are valuable, and several of them appear in the software section below, but they were not built specifically for the clinical environment.
Clinical AI governance software addresses additional requirements that follow from deploying AI in care delivery contexts. These include integration with EHR systems and PACS workflows so that governance monitoring sits in the same data path as clinical AI outputs, HIPAA-compliant data handling throughout the monitoring layer, alignment with FDA Software as a Medical Device (SaMD) lifecycle requirements for AI systems that qualify as regulated medical devices, bias and drift detection calibrated to clinical populations rather than general enterprise distributions, and audit trail depth sufficient to support post-market surveillance obligations.
The categories of capability you are looking for across any clinical AI governance platform include: a model inventory or catalog that covers all AI in your environment regardless of source (FDA-cleared vendor models, open-source models, internally developed models); continuous monitoring for data drift and model drift against clinical benchmarks; bias detection across patient demographic groups including race, age, sex, and socioeconomic indicators; audit logs that record model version, input data, output, and clinician action for each AI-assisted decision; and human oversight workflow support that routes flagged outputs to appropriate clinical reviewers rather than letting them silently pass through.
Evaluation criteria for clinical AI governance solutions
Before evaluating any specific platform or firm, it helps to be clear on which criteria are non-negotiable in a healthcare environment and which are differentiators.
FDA AI/ML lifecycle alignment. For AI systems that qualify as medical devices under FDA guidance, the organization deploying them is responsible for post-market surveillance, real-world performance monitoring, and transparency about model updates. A governance platform should support these obligations, not just general model monitoring. Ask specifically whether the vendor has mapped its monitoring capabilities to FDA's AI/ML-Based Software as a Medical Device action plan and the more recent draft guidance on predetermined change control plans.
EHR and FHIR compatibility. Clinical AI governance is only useful if the monitoring infrastructure can access the same data the AI is operating on. A platform that cannot connect to your EHR environment, PACS system, and FHIR endpoints will require custom integration work that adds cost and introduces latency into the monitoring layer. Ask what EHR integrations are production-supported (not just theoretical) and what the data access model looks like for HIPAA-covered data flowing through the monitoring layer.
Bias and drift monitoring calibrated for clinical populations. Generic drift detection tracks statistical shifts in model input distributions. Clinical AI governance requires demographic stratification: not just "the model's performance changed" but "the model's performance changed specifically for Black patients over 65" or "the model's false negative rate increased for Medicaid-enrolled patients." Ask how the platform segments monitoring by patient population and what demographic variables are tracked by default.
Audit trail depth. A clinician acting on an AI recommendation and then documenting in the EHR creates an implicit accountability chain. Clinical AI governance infrastructure should make that chain explicit: which model version produced the output, what the output was, who received it, and what action followed. This trail is necessary both for internal quality review and for responding to regulatory inquiries. Ask specifically what the platform captures at the individual inference level, not just in aggregate dashboards.
Human oversight workflow support. AI governance is not just monitoring; it is escalation. When monitoring detects an anomaly, something needs to happen. A governance platform that surfaces alerts into a dashboard but does not route them to a specific responsible clinician or quality officer leaves the oversight loop open. Ask how the platform routes flagged outputs and what integrations exist with existing clinical escalation workflows.
The vendor's own regulatory status. A vendor selling clinical AI governance software may itself have regulatory obligations depending on how its software is classified. Understand whether the platform vendor operates under a BAA, what their own HIPAA compliance posture looks like, and whether any component of their platform constitutes a regulated device.
Software and platform options
Ferrum Health
Ferrum Health is the most clinically native of the governance platforms in this list, built specifically for health systems rather than adapted from a general enterprise AI governance or ML observability model. The platform's core architecture is a Deployment Fabric: a governed integration layer that connects once to a health system's EMR, PACS, and clinical worklists and routes all AI models through a single controlled path. This means Ferrum sits in the actual clinical data flow rather than alongside it.
The Model Hub gives health system IT and clinical governance teams a unified catalog covering FDA-cleared vendor models, CE-marked models, open-source models, and internally developed models in a single governed environment. Continuous monitoring covers model performance, drift detection, and cross-site benchmarking, which is meaningful for health systems operating across multiple facilities where model performance can diverge by site.
Ferrum governs more than 45 million lives across more than 400 care sites internationally and processes more than 10,000 studies per day. The platform is available in the AWS Marketplace and Microsoft Azure Marketplace. For health systems evaluating clinical AI governance software with strong EHR and PACS integration requirements, Ferrum is the most direct fit.
Credo AI
Credo AI is an enterprise AI governance, risk, and compliance platform that health systems are using for policy management, AI system inventory, and regulatory framework alignment. The platform supports mapping to NIST AI RMF, EU AI Act, ISO 42001, and related standards. In April 2026, Credo AI joined the Coalition for Health AI (CHAI) Partner Program, positioning the platform more explicitly for healthcare regulatory environments alongside its existing enterprise coverage.
The platform's GAIA (Govern AI Assistant) feature is an AI governance agent designed to accelerate compliance documentation and policy assessment at the speed that modern AI deployment requires. Credo AI also participates in the Digital Medicine Society's FDA-convened community, which gives it ongoing visibility into FDA's evolving expectations for clinical AI.
Credo AI is the strongest fit for health systems and health plans that need a centralized AI inventory and compliance documentation layer, particularly organizations managing a large and growing portfolio of AI systems that need to be assessed against multiple regulatory frameworks simultaneously. It is less specific to clinical workflow integration than Ferrum Health, but stronger in enterprise governance program management across a complex regulatory landscape.
Arthur AI
Arthur AI is a model monitoring and AI governance platform built for production AI systems across regulated industries including healthcare. The platform covers bias detection, model explainability, drift monitoring, and LLM guardrails across tabular, NLP, computer vision, and large language model deployments. The unified evaluator interface allows teams to run bulk evaluation testing across model versions, which is useful for validating AI behavior before and after updates in a clinical environment where update-triggered performance changes carry clinical risk.
Arthur's differentiation for healthcare is its regulated industry orientation: the platform's bias detection and explainability features were built with the compliance requirements of financial services and healthcare in mind, not retrofitted from general ML observability. The 2026 updates include configurable trace retention policies and automated compliance checks, both relevant to health systems managing clinical AI audit obligations.
Arthur is the strongest fit for health systems with ML engineering teams who need a governance layer over internally developed models and vendor models running in production, particularly organizations that need explainability outputs that can be communicated to clinical staff rather than only to data scientists.
Arize AI
Arize AI is an AI observability and evaluation platform built on OpenTelemetry standards. Its Phoenix open-source observability platform has broad adoption in ML and LLM monitoring, and the enterprise AX platform extends that coverage with additional governance and evaluation features. For healthcare organizations, Arize's relevance is primarily in monitoring traditional ML models (risk scoring, readmission prediction, imaging classifiers) and extending that monitoring to LLM-based clinical tools.
Arize's healthcare fit is strongest for large health systems and academic medical centers that are already running ML models in production and need observability infrastructure that can scale to LLM workloads without requiring a separate platform. The open-source Phoenix path allows engineering teams to stand up monitoring with data residency controls aligned to HIPAA data handling requirements.
The limitation is that Arize was not designed specifically for clinical AI governance: healthcare-specific annotation workflows, clinical population demographic stratification, and FDA SaMD audit trail requirements are not first-class features. Organizations with complex clinical governance requirements are better served by pairing Arize's observability depth with a healthcare-specific governance framework, either through advisory or through a platform like Ferrum for the clinical workflow layer.
Fiddler AI
Fiddler AI is a production model monitoring platform with strong bias detection, drift monitoring, and explainability features, used in regulated industries including financial services, insurance, and healthcare. For health systems, Fiddler's primary use case is monitoring deployed predictive models, particularly those driving clinical or administrative decisions, for performance drift and demographic bias over time.
Fiddler's bias dashboards and real-time drift alerts are operationally mature, and the platform integrates with common MLOps infrastructure. For health systems that have deployed risk stratification models, clinical decision support tools, or administrative AI (prior authorization review, scheduling, billing) and need continuous production monitoring, Fiddler provides a capable monitoring layer with evidence of production use in regulated healthcare environments.
The same limitation as Arize applies: Fiddler is a general-purpose model monitoring platform that healthcare organizations use, not a clinical AI governance platform built specifically for healthcare. EHR integration, PACS workflow compatibility, and FDA SaMD lifecycle alignment require configuration and custom integration work rather than built-in support.
Advisory and consulting options
Tristella Advisors
Tristella's clinical AI governance advisory practice works with health systems, payers, and medtech organizations on the specific intersection of governance framework design and healthcare IT implementation. The distinction that matters here is the difference between a governance program that is compliant on paper and one that is usable in a real clinical environment.
Governance frameworks designed without clinical workflow context produce policies that clinical staff cannot follow, documentation requirements that IT teams cannot technically fulfill, and escalation procedures that do not map to how the organization actually makes decisions. Tristella's approach is to design governance programs that are grounded in how clinical AI actually operates in the health system's specific environment: which models are running, what data they access, which clinicians interact with their outputs, and what the existing quality and compliance infrastructure looks like.
Myra Salapare leads the practice with specific depth in HIPAA-compliant AI architecture, ONC and CMS interoperability compliance, clinical AI vendor evaluation, and Salesforce Health Cloud and Agentforce governance for healthcare AI workflows. Engagements are partner-led, which means the practitioner who designs the governance framework is the same person working through implementation alongside the organization's clinical and IT leadership.
The AI governance gap assessment is typically the right entry point: it identifies where the organization's exposure is before committing to a full governance program, and produces a prioritized view of what needs to be addressed and in what sequence.
Tristella is the right fit for health systems, payers, and medtech organizations that need a governance partner who combines clinical AI domain expertise with the healthcare IT context to make the program usable. It is not the right fit for organizations that need large-scale program delivery with a team of consultants embedded across multiple workstreams over a multi-year engagement.
Tristella AI governance services for healthcare
Deloitte
Deloitte's Applied AI and Digital Analytics practice for healthcare includes clinical AI governance as part of a broader advisory offering that covers AI strategy, governance framework design, regulatory compliance, and implementation oversight. For large health systems and health plans that need governance advisory to connect directly to broader digital transformation programs, change management at organizational scale, and ongoing regulatory compliance advisory, Deloitte's model covers that scope in a single firm relationship.
Deloitte's Center for Health Solutions publishes ongoing research on healthcare AI adoption and governance expectations, which gives its advisory practitioners current market context. The firm's 2025 healthcare AI adoption research surveyed 100 technology executives from large US health systems and health plans, grounding its recommendations in actual peer behavior rather than frameworks alone.
Deloitte is the strongest fit for large integrated delivery networks and academic medical centers whose AI governance program is embedded in a broader digital transformation or regulatory compliance initiative, and whose scale and organizational complexity require a firm that can resource multiple parallel workstreams. The engagement model is designed for organizations whose governance challenge is as much organizational change management as it is technical framework design.
Accenture
Accenture's health practice includes clinical AI governance advisory delivered through its Applied Intelligence and health technology consulting capabilities. The firm works with large health systems and payers on AI strategy, responsible AI frameworks, and the implementation infrastructure that makes governance programs operational at enterprise scale.
Accenture's differentiation in this space is the combination of management consulting advisory with technology implementation depth: for organizations whose governance program needs to be embedded in specific technology platforms (EHR systems, enterprise data platforms, clinical workflow tools), Accenture can resource both the advisory and the technical implementation alongside each other. The firm's scale means it can staff governance engagements at the size that large health system transformation programs require.
Accenture is the strongest fit for large health systems and national health plans with complex, multi-facility AI governance requirements where the consulting scope includes both governance framework design and the technical implementation work of embedding governance into existing clinical and administrative systems.
How to choose: software, advisory, or both
The practical decision is about sequence, not just preference.
Organizations without a governance foundation should start with advisory. Clinical AI governance software monitors AI systems against defined policies and thresholds. If you have not defined what policies and thresholds apply in your environment, the monitoring generates data that your team does not know how to act on. The foundation that advisory builds, which models are in scope, what constitutes acceptable bias levels for each use case, who owns escalation for different alert types, what documentation an audit requires, is what gives the software something meaningful to operationalize.
Organizations with a governance framework in place need software to scale it. A governance program that runs on spreadsheets, periodic manual audits, and email-based escalation will not scale as the number of AI models in clinical use grows. Software provides the continuous monitoring, automated alerting, and audit trail depth that manual governance cannot maintain at volume. The framework your advisory work produced becomes the configuration for the monitoring platform.
Most mature health systems need both in sequence. The pattern that produces durable results is: advisory to design the governance program and define the policies, followed by platform selection and implementation to operationalize those policies at scale, with ongoing advisory to update the framework as the regulatory environment and the AI portfolio evolve.
The relationship between the AI governance software vs. advisory post covers this in more detail, including how to evaluate which type of support fills the more urgent gap in your current situation.
Where to start
For health systems that have not yet conducted a structured review of their clinical AI governance posture, the AI governance gap assessment identifies where the exposure is before a regulator, accreditor, or plaintiff identifies it first. The assessment covers model inventory, policy framework maturity, monitoring infrastructure, escalation design, and documentation, and produces a prioritized view of what needs to be addressed and in what order.
For organizations that want to understand where AI governance fits in the broader clinical IT strategy, the healthcare AI adoption scorecard covers FHIR readiness, AI infrastructure, and governance maturity as part of a single assessment.
The AI governance failures post documents what happens to organizations that deploy clinical and administrative AI without adequate governance, with the actual costs, regulatory consequences, and legal outcomes across six documented cases.
Myra Salapare leads Tristella's clinical AI governance and healthcare IT strategy practice. Contact us to discuss your organization's governance posture and what a structured review involves.
Related reading: